These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 2577313)

  • 21. Acetylation of procaine amide in man studied with a new gas chromatographic method.
    Karlsson E; Molin L; Norlander B; Sjöqvist F
    Br J Clin Pharmacol; 1974 Dec; 1(6):467-75. PubMed ID: 22454932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ventricular tachycardia following the administration of quinidine.
    WETHERBEE DG; HOLZMAN D; BROWN MG
    Am Heart J; 1952 Jan; 43(1):89-96. PubMed ID: 14885097
    [No Abstract]   [Full Text] [Related]  

  • 23. THE METABOLISM OF DIGOXIN IN NORMAL SUBJECTS.
    MARCUS FI; KAPADIA GJ; KAPADIA GG
    J Pharmacol Exp Ther; 1964 Aug; 145():203-9. PubMed ID: 14214418
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies with tritiated digoxin in human subjects after intravenous administration.
    DOHERTY JE; PERKINS WH
    Am Heart J; 1962 Apr; 63():528-36. PubMed ID: 13886959
    [No Abstract]   [Full Text] [Related]  

  • 25. Tritiated digoxin studies in human subjects.
    DOHERTY JE; PERKINS WH; MITCHELL GK
    Arch Intern Med; 1961 Oct; 108():531-9. PubMed ID: 13886957
    [No Abstract]   [Full Text] [Related]  

  • 26. Quinidine concentration in blood and excretion in urine following parenteral administration as related to congestive heart failure.
    DITLEFSEN EM
    Acta Med Scand; 1957 Nov; 159(2):105-9. PubMed ID: 13497617
    [No Abstract]   [Full Text] [Related]  

  • 27. Quinidine as a cause of sudden death.
    THOMSON GW
    Circulation; 1956 Nov; 14(5):757-65. PubMed ID: 13374851
    [No Abstract]   [Full Text] [Related]  

  • 28. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
    Bax ND; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered prazosin pharmacokinetics in congestive heart failure.
    Baughman RA; Arnold S; Benet LZ; Lin ET; Chatterjee K; Williams RL
    Eur J Clin Pharmacol; 1980 Jun; 17(6):425-8. PubMed ID: 7398734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Furosemide in patients with heart failure: shift in dose-response curves.
    Brater DC; Chennavasin P; Seiwell R
    Clin Pharmacol Ther; 1980 Aug; 28(2):182-6. PubMed ID: 7398185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic disposition and diuretic effect of frusemide in acute pulmonary oedema.
    Perez J; Sitar DS; Ogilvie RI
    Br J Clin Pharmacol; 1980 May; 9(5):471-8. PubMed ID: 7397063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prazosin kinetics in essential hypertension.
    Chau NP; Flouvat BL; Le Roux E; Safar ME
    Clin Pharmacol Ther; 1980 Jul; 28(1):6-11. PubMed ID: 7389255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose requirements of hydralazine in patients with severe chronic congestive heart failure.
    Packer M; Meller J; Medina N; Gorlin R; Herman MV
    Am J Cardiol; 1980 Mar; 45(3):655-60. PubMed ID: 7355762
    [No Abstract]   [Full Text] [Related]  

  • 34. Tocainide kinetics after intravenous and oral administration in healthy subjects and in patients with acute myocardial infarction.
    Graffner C; Conradson TB; Hofvendahl S; Rydén L
    Clin Pharmacol Ther; 1980 Jan; 27(1):64-71. PubMed ID: 7351118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Verapamil kinetics in normal subjects and patients with coronary artery spasm.
    Freedman SB; Richmond DR; Ashley JJ; Kelly DT
    Clin Pharmacol Ther; 1981 Nov; 30(5):644-52. PubMed ID: 7297023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prazosin kinetics in hypertension.
    Grahnén A; Seideman P; Lindström B; Haglund K; von Bahr C
    Clin Pharmacol Ther; 1981 Oct; 30(4):439-46. PubMed ID: 7285477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between alpha 1-acid glycoprotein and lidocaine disposition in myocardial infarction.
    Routledge PA; Shand DG; Barchowsky A; Wagner G; Stargel WW
    Clin Pharmacol Ther; 1981 Aug; 30(2):154-7. PubMed ID: 7249498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between amrinone plasma concentration and cardiac index.
    Edelson J; LeJemtel TH; Alousi AA; Biddlecome CE; Maskin CS; Sonnenblick EH
    Clin Pharmacol Ther; 1981 Jun; 29(6):723-8. PubMed ID: 7226703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors influencing procainamide total body clearance in the immediate postmyocardial infarction period.
    Wyman MG; Goldreyer BN; Cannon DS; Ludden TM; Lalka D
    J Clin Pharmacol; 1981 Jan; 21(1):20-5. PubMed ID: 7217340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure.
    Landmark K; Bredesen JE; Thaulow E; Simonsen S; Amlie JP
    Eur J Clin Pharmacol; 1981 Feb; 19(3):187-92. PubMed ID: 7215416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.